Journal
NATURE GENETICS
Volume 46, Issue 12, Pages 1267-1273Publisher
NATURE PORTFOLIO
DOI: 10.1038/ng.3126
Keywords
-
Categories
Funding
- Ministry of Health, Labour and Welfare of Japan
- US National Human Genome Research Institute (NHGRI) [5U541-IG003273]
- National Cancer Institute (NCI) [HHSN261201000053C, P30 CA125123]
- National Institute of Biomedical Innovation (NIBIO, Japan)
- National Cancer Center Research and Development Funds (Japan) [23-A-8]
Ask authors/readers for more resources
Diverse epidemiological factors are associated with hepatocellular carcinoma (HCC) prevalence in different populations. However, the global landscape of the genetic changes in HCC genomes underpinning different epidemiological and ancestral backgrounds still remains uncharted. Here a collection of data from 503 liver cancer genomes from different populations uncovered 30 candidate driver genes and 11 core pathway modules. Furthermore, a collaboration of two large-scale cancer genome projects comparatively analyzed the trans-ancestry substitution signatures in 608 liver cancer cases and identified unique mutational signatures that predominantly contribute to Asian cases. This work elucidates previously unexplored ancestry-associated mutational processes in HCC development. A combination of hotspot TERT promoter mutation, TERT focal amplification and viral genome integration occurs in more than 68% of cases, implicating TERT as a central and ancestry-independent node of hepatocarcinogenesis. Newly identified alterations in genes encoding metabolic enzymes, chromatin remodelers and a high proportion of mTOR pathway activations offer potential therapeutic and diagnostic opportunities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available